Glucose dysregulation and mirtazapine-induced weight gain.
Fisfalen
Maria E
ME
Hsiung
Robert C
RC
D000328:Adult; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects* / Q000627:therapeutic use; D001786:Blood Glucose / Q000032:analysis / Q000378:metabolism*; D015992:Body Mass Index; D019970:Cocaine-Related Disorders / Q000150:complications / Q000175:diagnosis; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000139:chemically induced* / Q000378:metabolism; D017831:Diagnosis, Dual (Psychiatry); D005260:Female; D006801:Humans; D008803:Mianserin / Q000009:adverse effects* / Q000031:analogs & derivatives / Q000627:therapeutic use; D000078785:Mirtazapine; D009765:Obesity; D015430:Weight Gain / Q000187:drug effects*
D000929:Antidepressive Agents, Tricyclic; D001786:Blood Glucose; D008803:Mianserin; D000078785:Mirtazapine